Hikma Pharmaceuticals PLC
LSE:HIK

Watchlist Manager
Hikma Pharmaceuticals PLC Logo
Hikma Pharmaceuticals PLC
LSE:HIK
Watchlist
Price: 1 794 GBX -0.83% Market Closed
Market Cap: 4B GBX
Have any thoughts about
Hikma Pharmaceuticals PLC?
Write Note

Hikma Pharmaceuticals PLC
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hikma Pharmaceuticals PLC
Gross Profit Peer Comparison

Comparables:
GSK
AZN
VRNA
INDV
DPH

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Hikma Pharmaceuticals PLC
LSE:HIK
Gross Profit
$1.4B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
5%
GlaxoSmithKline PLC
LSE:GSK
Gross Profit
ÂŁ22.9B
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
3%
AstraZeneca PLC
LSE:AZN
Gross Profit
$40.4B
CAGR 3-Years
22%
CAGR 5-Years
17%
CAGR 10-Years
7%
Verona Pharma PLC
NASDAQ:VRNA
Gross Profit
$5.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Indivior PLC
LSE:INDV
Gross Profit
$952m
CAGR 3-Years
16%
CAGR 5-Years
4%
CAGR 10-Years
-1%
Dechra Pharmaceuticals PLC
LSE:DPH
Gross Profit
ÂŁ429.6m
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
16%

See Also

What is Hikma Pharmaceuticals PLC's Gross Profit?
Gross Profit
1.4B USD

Based on the financial report for Jun 30, 2024, Hikma Pharmaceuticals PLC's Gross Profit amounts to 1.4B USD.

What is Hikma Pharmaceuticals PLC's Gross Profit growth rate?
Gross Profit CAGR 10Y
5%

Over the last year, the Gross Profit growth was 4%. The average annual Gross Profit growth rates for Hikma Pharmaceuticals PLC have been 5% over the past three years , 5% over the past five years , and 5% over the past ten years .

Back to Top